Analgesic Solutions Presents Data On The Use Of MADDERS To Assess Potentially Abuse-Related Events In Clinical Trials At The Post author:Sam Post published:June 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like The Biggest Winners and Losers of JPM 2018 January 16, 2018 Bristol-Myers Squibb's Stock Topples as Kidney Cancer Drug Flunks Phase III Study August 15, 2017 <b>ISPE</b> Releases The New Cultural Excellence Report May 7, 2017